Immune thrombocytopenic purpura is scientifically called primary immune thrombocytopenia, and most patients can be cured, but it is easy for the disease to recur. It is recommended to go to the hospital in time and actively cooperate with the treatment. 1. Primary immune thrombocytopenia is mainly characterized by a decrease in platelet count and a tendency to bleed. This disease belongs to autoimmune disease, and immune abnormality is its main pathogenesis. At present, there is no specific drug and it is difficult to cure it completely, but if you accept the treatment actively, you can get a better result. The specific treatment of primary immune thrombocytopenia varies from person to person. Generally, it can be treated with glucocorticoids, such as prednisone and dexamethasone under the guidance of the doctor, and splenectomy can also be performed if necessary. If necessary, splenectomy can also be performed. After treatment, the disease can usually be better controlled. 2. However, if the condition of some patients is prolonged and difficult to be cured after treatment, human thrombopoietin, azathioprine, rituximab, retinoic acid, decitabine and other second- and third-line drug therapy can be given. Specific treatment should be carried out under the guidance of physicians.